# Refractory Status Epilepticus Treatment Study

> **NCT01586208** · PHASE3 · COMPLETED · sponsor: **Hospital Universitari de Bellvitge** · enrollment: 5 (actual)

## Conditions studied

- Grand Mal Status Epilepticus
- Non-convulsive Status Epilepticus

## Interventions

- **DRUG:** valproic acid (VPA)

## Key facts

- **NCT ID:** NCT01586208
- **Lead sponsor:** Hospital Universitari de Bellvitge
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2012-05
- **Final completion:** 2012-10
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2013-03-12

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01586208

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01586208, "Refractory Status Epilepticus Treatment Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01586208. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*